Erythropoietin reverts cognitive impairment and alters the oxidative parameters and energetic metabolism in sepsis animal model

Journal of Neural Transmission

Volumn 119, Issue 11, 2012, Pages 1267-1274

  Comim, Clarissa M ^a   Cassol Jr , Omar J ^a   Abreu, Igor ^a   Moraz, Thais ^a   Constantino, Larissa S ^a   Vuolo, Francieli ^a   Galant, Letícia S ^a   De Rochi, Natália ^a   Dos Santos Morais, Meline O ^a   Scaini, Giselli ^a   Barichello, Tatiana ^a   Streck, Emílio L ^a   Quevedo, João ^a,b   Dal Pizzol, Felipe ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b PPGCS   (Brazil)

Author keywords

Energetic metabolism; Erythropoietin; Hippocampus; Oxidative stress; Rats; Sepsis

Indexed keywords

ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; EXPERIMENTAL MODEL; HIPPOCAMPUS; LIGATION; MALE; MEMORY; METABOLISM; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PERFORATION; PRIORITY JOURNAL; RAT; SEPSIS; SHAM PROCEDURE;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; CITRATE (SI)-SYNTHASE; COGNITION DISORDERS; CREATINE KINASE; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENERGY METABOLISM; ERYTHROPOIETIN; INHIBITION (PSYCHOLOGY); LIGATION; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEPSIS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84869501110     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0774-2     Document Type: Article

References (64)

1. Abdelrahman M, Rafi A, Ghacha R, Qayyum T, Karkar A (2004) Posttransplant erythrocytosis: a review of 47 renal transplant recipients. Saudi J Kidney Dis Transpl (an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia) 4:433-439
2. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
3. Akimoto T, Kusano E, Muto S, Fujita N, Okada K, Saito T, Komatsu N, Ono S, Ebata S, Ando Y, Homma S, Asano Y (1999) The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells. J hypertens 9:1249-1256
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310
5. Aoshiba K, Onizawa S, Tsuji T, Nagai A (2009) Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med 37:889-898
6. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C (2005) Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 75:1100-1105
7. Bannister JV, Calabrese L (1987) Assays for superoxide dismutase. Methods Biochem Anal 32:279-312
8. Barichello T, Martins MR, Reinke A, Feier G, Ritter C, Quevedo J, Dal-Pizzol F (2005) Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 33:221-223
9. Barichello T, Fortunato JJ, Vitali AM, Feier G, Reinke A, Moreira JC, Quevedo J, Dal-Pizzol F (2006) Oxidative variables in the brain after sepsis induced by cecal ligation and perforation. Crit Care Med 34:886-889
10. Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A (2009) Recombinant human erythropoiesisstimulating agents and mortality in patients with cancer: a metaanalysis of randomized trials. Lancet 373:1532-1542
11. Cain SM, Curtis SE (1991) Experimental models of pathologic oxygen supply dependency. Crit Care Med 19:603-612
12. Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, Buemi M (2000) Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 401:349-356
13. Cassina A, Radi R (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328:309-316
14. Chandra V, Pandav R, Laxminarayan R, Tanner C, Manyam B, Rajkumar S, Silberberg D, Brayne C, Chow J, Herman S, Hourihan F, Kasner S, Morillo L, Ogunniyi A, Theodore W, Zhang ZX (2006) Neurological disorders. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P (eds) Disease control priorities in developing countries, 2nd edn. World Bank, Washington, DC
15. Chao CC, Hu S, Peterson PK (1995) Glia, cytokines, and neurotoxicity. Crit Rev Neurobiol 9:189-205
16. Comim CM, Rezin GT, Scaini G, Di-Pietro PB, Cardoso MR, Petronilho FC, Ritter C, Streck EL, Quevedo J, Dal-Pizzol F (2008) Mitochondrial respiratory chain and creatine kinase activities in rat brain after sepsis induced by cecal ligation and perforation. Mitochondrion 8:313-318
17. Comim CM, Constantino LC, Barichello T, Streck EL, Quevedo J, Dal-Pizzol F (2009) Cognitive impairment in the septic brain. Curr Neurovasc Res 6:194-203
18. Comim CM, Cassol-Jr OJ, Constantino LC, Petronilho F, Constantino LS, Stertz L, Kapczinski F, Barichello T, Quevedo J, Dal-Pizzol F (2010) Depressive-like parameters in sepsis survivor rats. Neurotoxic Res 17:279-286
19. Comim CM, Cassol-Jr OJ, Constantino LS, Felisberto F, Petronilho F, Rezin GT, Scaini G, Daufenbach JF, Streck EL, Quevedo J, Dal-Pizzol F (2011) Alterations in inflammatory mediators, oxidative stress parameters and energetic metabolism in the brain of sepsis survivor rats. Neurochem Res 36:304-311
20. Cuzzocrea S, Di PR, Mazzon E, Patel NS, Genovese T, Muia C, Crisafulli C, Caputi AP, Thiemermann C (2006) Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 34:1168-1177
21. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296-327
22. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 9:3717-3720
23. Ehrenreich H, Degner D, Meller J, Brines M, Be'hé M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Bruck W, Ruther E, Cerami A, Becker W, Sire'n AL (2004) Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 9:42-54
24. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jahnig P, Herrmann M, Knauth M, Bahr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C, EPO Stroke Trial Group (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40:e647-e656
25. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407-421
26. Farrell F, Lee A (2004) The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 5:18-30
27. Fauchère JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M, Bucher HU (2008) An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 122:375-382
28. Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23-36
29. Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236-245
30. Harris KW, Winkelmann JC (1996) Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma. Am J Hematol 52:8-13
31. Hu S, Peterson PK, Chao CC (1997) Cytokine-mediated neuronal apoptosis. Neurochem Int 30:427-431
32. Hughes BP (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7:597-603
33. Iwashyna TJ, Ely EW, Smith DM, Langa KM (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787-1794
34. Jelkmann W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 2:449-489
35. Kafa IM, Uysal M, Bakirci S, Ayberk Kurt M (2010) Sepsis induces apoptotic cell death in different regions of the brain in a rat model of sepsis. Acta Neurobiol Exp 70:246-260
36. Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346-357
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
38. Maiese K, Li F, Chong ZZ (2004) Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci 11:577-583
39. Marshall JC, Deitch C, Moldawer LL, Opal S, Redl H, Van der Poll T (2005) Preclinical models of shock and sepsis: what can they tell us? Shock 24:1-6
40. Messaris E, Memos N, Chatzigianni E, Konstadoulakis MM, Menenakos E, Katsaragakis S, Voumvourakis C, Androulakis G (2004) Time-dependent mitochondrial-mediated programmed neuronal cell death prolongs survival in sepsis. Crit Care Med 32:1764-1770
41. Miro O, Cardellach F, Barrientos A, Casademont J, Rotig A, Rustin P (1998) Cytochrome c oxidase assay in minute amounts of human skeletal muscle using single wavelength spectrophotometers. J Neurosci Methods 80:107-111
42. Mitra A, Bansal S, Wang W, Falk S, Zolty E, Schrier RW (2007) Erythropoietin ameliorates renal dysfunction during endotoxaemia. Nephrol Dial Transplant 22:2349-2353
43. Nelson DP, Samsel RW, Wood LDH, Schumacker PT (1988) Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia. J Appl Physiol 64:2410-2419
44. Quevedo J, Vianna MR, Roesler R, Izquierdo I (1999) Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus. Learn Mem 6:600-607
45. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, Schumann RR (1996) Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216:39-81
46. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL, Platt R (1997) Academic Medical Center Consortium Sepsis Project Working Group: epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234-238
47. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT (2005) Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 30:144-157
48. Sharples EJ, Yaqoob MM (2006) Erythropoietin and acute renal failure. Sem Nephrol 4:325-331
49. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM (2004) Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15:2115-2224
50. SOlling C, Christensen AT, Nygaard U, Krag S, FrOkiaer J, Wogensen L, Krog J, TOnnesen EK (2011a) Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia. Acta Anaesthesiol Scand 55(4):411-421
51. SOlling C, Nygaard U, Christensen AT, Wogensen L, Krog J, TOnnesen EK (2011b) Lymphocyte apoptosis is resistant to erythropoietin in porcine endotoxemia. APMIS 119:143-154
52. Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, Hinshaw LB (1990) Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 18:801-806
53. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Caputi AP (1999) Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 2:482-488
54. Srere PA (1969) Citrate synthase. Methods Enzymol 13:3-11
55. Streck EL, Comim CM, Barichello T, Quevedo J (2008) The septic brain. Neurochem Res 33:2171-2177
56. Tonelli M, Hemmelgarn B, Reiman T, Manns B, Reaume MN, Lloyd A, Wiebe N, Klarenbach S (2009) Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis. CMAJ 180:E62-E71
57. Tuon L, Comim CM, Petronilho F, Barichello T, Izquierdo I, Quevedo J, Dal-Pizzol F (2008) Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med 34:1724-1731
58. Vandijck D, Decruyenaere JM, Blot SI (2006) The value of sepsis definitions in daily ICU-practice. Acta Clin Belg 6:220-226
59. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW (2004) Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19:348-355
60. Westenfelder C, Dl Biddle, Rl Baranowski (1999) Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 3:808-820
61. Wu ZS, Zhou GZ, Jiang JH, Shen GL, Yu RQ (2006) Gold colloidbienzyme conjugates for glucose detection utilizing surfaceenhanced Raman scattering. Talanta 3:533-539
62. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y (1996) Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 239:494-500
63. Yamamoto M, Koshimura K, Sohmiya M, Murakami Y, Kato Y (2004) Effect of erythropoietin on nitric oxide production in the rat hippocampus using in vivo brain microdialysis. Neuroscience 128:163-168
64. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA (1990) The encephalopathy associated with septic illness. Clin Invest Med 13:297-304